RIGLNasdaq United States
Market cap
$750.370 M
$40.17 +2.42%
Close of 7 Aug 2026
Revenue
$294.3M
#2145 by revenue
Earnings
$367.0M
#755 by earnings
Shares outstanding
18,679,864
Latest filing cover page
P/E ratio
2.0
Cap ÷ net income
Where these numbers come from
Share counts and financials for Rigel Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.